N-[5-(2,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-4-[(3,5-dimethylpiperidin-1-yl)sulfonyl]benzamide结构式
|
常用名 | N-[5-(2,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-4-[(3,5-dimethylpiperidin-1-yl)sulfonyl]benzamide | 英文名 | N-[5-(2,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-4-[(3,5-dimethylpiperidin-1-yl)sulfonyl]benzamide |
|---|---|---|---|---|
| CAS号 | 533870-31-4 | 分子量 | 500.6 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C24H28N4O6S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-[5-(2,4-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-4-[(3,5-dimethylpiperidin-1-yl)sulfonyl]benzamide |
|---|
| 分子式 | C24H28N4O6S |
|---|---|
| 分子量 | 500.6 |
| InChIKey | LATMPCVMUBNZRC-UHFFFAOYSA-N |
| SMILES | CC1CC(CN(C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)NC3=NN=C(O3)C4=C(C=C(C=C4)OC)OC)C |
|
实验名称:Identification of CBX7 inhibitors - Primary Alpha Screen
来源:15290
靶标:N/A
External Id:CBX7-Alpha-primary
|